Announcements
- 2023.11.28 (1) PROPOSED GRANTING OF REPURCHASE MANDATE TO REPURCHASE H SHARES; (2) PROPOSED ADOPTION OF THE H SHARE AWARD AND TRUST SCHEME; (3) PROPOSED AUTHORIZATION TO THE BOARD AND/OR THE DELEGATEE(S) TO HANDLE MATTERS PERTAINING TO THE H SHARE AWARD AND TRUST SCHEME; (4) PROPOSED SALE OF EQUITY INTEREST IN THE TARGET COMPANY; AND (5) NOTICE OF THE 2023 SECOND EXTRAORDINARY GENERAL MEETING
- 2023.11.28 PROXY FORM FOR THE 2023 SECOND EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, DECEMBER 15, 2023
- 2023.11.28 NOTICE OF THE 2023 SECOND EXTRAORDINARY GENERAL MEETING
- 2023.11.28 (1) PROPOSED GRANTING OF REPURCHASE MANDATE TO REPURCHASE H SHARES; (2) PROPOSED ADOPTION OF THE H SHARE AWARD AND TRUST SCHEME; (3) PROPOSED AUTHORIZATION TO THE BOARD AND/OR THE DELEGATEE(S) TO HANDLE MATTERS PERTAINING TO THE H SHARE AWARD AND TRUST SCHEME; AND (4) THE 2023 SECOND EXTRAORDINARY GENERAL MEETING
- 2023.11.28 DISCLOSEABLE TRANSACTION PROPOSED SALE OF EQUITY INTEREST IN THE TARGET COMPANY
- 2023.11.28 (1) PROPOSED GRANTING OF REPURCHASE MANDATE TO REPURCHASE H SHARES; (2) PROPOSED ADOPTION OF THE H SHARE AWARD AND TRUST SCHEME; (3) PROPOSED AUTHORIZATION TO THE BOARD AND/OR THE DELEGATEE(S) TO HANDLE MATTERS PERTAINING TO THE H SHARE AWARD AND TRUST SCHEME; AND (4) THE 2023 SECOND EXTRAORDINARY GENERAL MEETING
- 2023.11.28 VOLUNTARY ANNOUNCEMENT ONE-YEAR RESULTS OF THE CONFIRMATORY CLINICAL TRIAL OF LUX-VALVE RELEASED AT THE PCR LONDON VALVES 2023
- 2023.11.13 SIMULOCK SUCCESSFULLY COMPLETES IMPLANTATION SURGERY FOR THE FIRST CONFIRMATORY CLINICAL TRIAL
- 2023.11.03 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
- 2023.10.31 VOLUNTARY ANNOUNCEMENT LUX-VALVE PLUS TRAVEL II RESULTS RELEASED AT THE 2023 TCT IN THE U.S.
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
